Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Laudadio J, Deininger MWN, Mauro MJ, Druker BJ, Press RD. An intron-derived insertion/truncation mutation in the BCR-ABL kinase domain in chronic myeloid leukemia patients undergoing kinase inhibitor therapy. J Mol Diagn 2008;10:177-80. [PMID: 18276770 DOI: 10.2353/jmoldx.2008.070128] [Citation(s) in RCA: 50] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open

For:	Laudadio J, Deininger MWN, Mauro MJ, Druker BJ, Press RD. An intron-derived insertion/truncation mutation in the BCR-ABL kinase domain in chronic myeloid leukemia patients undergoing kinase inhibitor therapy. J Mol Diagn 2008;10:177-80. [PMID: 18276770 DOI: 10.2353/jmoldx.2008.070128] [Citation(s) in RCA: 50] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open

Number	Cited by Other Article(s)
51	Quigley NB, Henley DC, Hubbard RA, Laudadio J, Press RD. ABL kinase domain pseudoexon insertion is not uncommon in BCR-ABL transcripts. J Mol Diagn 2008;10:475-6; author reply 476. [PMID: 18687796 DOI: 10.2353/jmoldx.2008.080055] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open Abstract Collapse Key Words Collapse MESH Headings Antineoplastic Agents/therapeutic use Benzamides Exons/genetics Fusion Proteins, bcr-abl/genetics Humans Imatinib Mesylate Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics Mutagenesis, Insertional Phosphotransferases/chemistry Phosphotransferases/genetics Piperazines/therapeutic use Protein Structure, Tertiary/genetics Pyrimidines/therapeutic use Transcription, Genetic Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

Quigley NB, Henley DC, Hubbard RA, Laudadio J, Press RD. ABL kinase domain pseudoexon insertion is not uncommon in BCR-ABL transcripts. J Mol Diagn 2008;10:475-6; author reply 476. [PMID: 18687796 DOI: 10.2353/jmoldx.2008.080055] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open